NASDAQ:MTAC

MedTech Acquisition (MTAC) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free MTAC Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $8.96
▼
$12.83
50-Day Range: $9.34
▼
$11.34
52-Week Range: $8.43
▼
$12.83

Volume: 183,276 shs
Average Volume: 9,656 shs
Market Capitalization: $83.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get MedTech Acquisition alerts:

Ad Banyan Hill Publishing

The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

About MedTech Acquisition Stock (NASDAQ:MTAC)

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

Ad DTI

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

MTAC Stock News Headlines

January 23, 2024 | msn.com

Johnson & Johnson’s MedTech performance augurs well for industry: analysts

January 23, 2024 | msn.com

Johnson & Johnson’s earnings beat estimates with boost from medtech sales

April 19, 2024 | TradeSmith (Ad)

The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

November 29, 2023 | forbes.com

5 Tips To Ensure Product-Market Fit In Medtech

November 15, 2023 | bizjournals.com

Westminster oncology company holds first earnings call since going public

November 14, 2023 | finance.yahoo.com

TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update

September 25, 2023 | forbes.com

The Art Of A Profitable Medtech Exit

August 8, 2023 | markets.businessinsider.com

Pre-market Movers: MTAC, AYX, DDOG, IFF, CHGG…

April 19, 2024 | TradeSmith (Ad)

The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

August 3, 2023 | finance.yahoo.com

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

July 20, 2023 | msn.com

Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform

May 30, 2023 | msn.com

Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson

May 10, 2023 | investing.com

LAVA Medtech Acquisition Corp (LVAC)

April 26, 2023 | forbes.com

Six Ways To Lead The Charge In Medtech

April 20, 2023 | finance.yahoo.com

TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases

February 21, 2023 | finance.yahoo.com

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

December 8, 2022 | yahoo.com

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

November 16, 2022 | finance.yahoo.com

TriSalus Goes SPAC Way To Fund Pressure-Enabled Drug Delivery Tech Based Cancer Trials

November 14, 2022 | finance.yahoo.com

TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation

August 9, 2022 | finance.yahoo.com

Global MedTech Healthcare IT Industry Competitive Landscape

July 27, 2022 | apnews.com

LSI Emerging Medtech Summit 2022 Brings Venture Capital and Entrepreneurs Closer in New Event in Europe

July 15, 2022 | benzinga.com

Ophthalmic Devices Market is expected to be worth USD 83.1 billion by 2030, with a CAGR of 4.7%.

June 12, 2022 | seekingalpha.com

Medtronic: Stable Growth Ahead

May 31, 2022 | msn.com

3 Med-Tech Stocks With Incredible Potential

May 27, 2022 | seekingalpha.com

Medtronic plc (MDT) CEO Geoff Martha on Q4 2022 Results - Earnings Call Transcript

April 8, 2022 | finance.yahoo.com

MedTech Acquisition Corporation (MTAC)

March 10, 2022 | seekingalpha.com

SPAC MedTech Acquisition, Memic Innovative Surgery call off planned merger

See More Headlines

Receive MTAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical laboratories
Sub-Industry: N/A
Current Symbol: NASDAQ:MTAC
CUSIP: N/A
CIK: 1826667
Web: N/A
Phone: 908-391-1288
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $5.54 million
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -17.92%
Return on Assets: -1.48%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.03
Quick Ratio: 0.03

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: $0.89 per share
Price / Cash Flow: 12.80
Book Value: ($2.04) per share
Price / Book: -5.56

Miscellaneous

Outstanding Shares: 7,390,000
Free Float: 1,952,000
Market Cap: $83.80 million
Optionable: Not Optionable
Beta: -0.04

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Christopher C. Dewey (Age 79)
CEO & Director
Mr. David J. Matlin J.D. (Age 61)
CFO & Director
Mr. Robert H. Weiss J.D. (Age 64)
Chief Admin. Officer & Sec.

Key Competitors

View All Competitors

This page (NASDAQ:MTAC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MedTech Acquisition (MTAC) Stock Price, News & Analysis

About MedTech Acquisition Stock (NASDAQ:MTAC)

MTAC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info